Insights Into Participating in Studies for Uterine Cancer
This study is looking into why people with uterine cancer decide to join clinical trials, and what makes them stay in a trial until it's finished. Researchers want to understand the challenges and reasons people might drop out. There are no specific treatments or drugs being tested in this study. You might be able to join if you are 18 or older, have been diagnosed with uterine cancer, and haven't had any treatment for it yet. The study aims to enroll 500 people. Success for this study means understanding how many people decide to join a uterine cancer trial within 3 months, and how many of those people complete the trial after 12 months. The current status of this study is unclear.
- Study design
- This is an observational study, meaning researchers will gather information without giving any specific treatment. It plans to include 500 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Researchers will look at how many people join a trial at 3 months, and how many remain in a trial at 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Insights Into Participating in Studies for Uterine Cancer
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of patients who decide to enroll in a uterine cancer clinical research3 months
- Rate of patients who remain in a uterine cancer clinical trial to trial completion12 months